Holen Sie sich die Stockscreener-App
21.83
2.45%
0.5228
Schlusskurs vom Vortag:
$21.31
Offen:
$21.35
24-Stunden-Volumen:
21,630
Relative Volume:
0.75
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.30%
1M Leistung:
+6.84%
6M Leistung:
-2.80%
1J Leistung:
-11.70%
1-Tages-Spanne:
$21.35
$21.83
1-Wochen-Bereich:
$21.05
$21.83
52-Wochen-Spanne:
$17.26
$25.80
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
Firmenname
Ishares Genomics Immunology And Healthcare Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IDNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDNA
Ishares Genomics Immunology And Healthcare Etf
|
21.83 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
309.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
628.86 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
631.74 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
244.81 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
561.25 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Genomics Immunology And Healthcare Etf Aktie (IDNA) Neueste Nachrichten
When (XDNA) Moves Investors should Listen (XDNA:CA) - news.stocktradersdaily.com
(XDNA) Strategic Investment Guide (XDNA:CA) - news.stocktradersdaily.com
IDNA Dividend Declared: Navigating Sustainability and Growth in Healthcare ETFs - AInvest
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
(XDNA) Pivots Trading Plans and Risk Controls (XDNA:CA) - news.stocktradersdaily.com
(XDNA) Risk-Controlled Trading Report (XDNA:CA) - news.stocktradersdaily.com
Objective long/short (XDNA) Report (XDNA:CA) - news.stocktradersdaily.com
(XDNA) Trading Advice (XDNA:CA) - news.stocktradersdaily.com
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal - Benzinga
(XDNA) Stock Trading Blueprint (XDNA:CA) - news.stocktradersdaily.com
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus - Zacks Investment Research
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion - Benzinga
IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (NYSEARCA:IDNA) - Seeking Alpha
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm? - Benzinga
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Future Health: Harnessing Innovations In Healthcare - Syfe
The Healthcare Sector: 5 Things To Know - Syfe
7 Best Biotech ETFs In Canada for March 2025 - Wealth Awesome
Has Biotechnology Bottomed Out? - Master Investor
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
IDNA ETF: Continues To Underperform, But With Long Run Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing - US News Money
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering and Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - InvestorPlace
3 Themes Growth and Tech Investors May Want to Consider in 2023 - Nasdaq
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher - InvestorPlace
Biotech ETFs Slip After Novavax Cuts 2022 Guidance - ETF Trends
BlackRock's iShares predicts 3 'megatrend' themes will accelerate in 2022 — and identifies the best ways for investors to capture their gains - Business Insider
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
3 genome ETFs to watch in 2021 - CMC Markets
iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant (NYSEARCA:IDNA) - Seeking Alpha
3 ETFs For More Moderna Bets - Yahoo
2 Biotechnology ETFs That Could Be Good For Diversification - ETF Trends
iShares Lists Cybersecurity and Genomics ETFs - ETF Trends
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
Finanzdaten der Ishares Genomics Immunology And Healthcare Etf-Aktie (IDNA)
Es liegen keine Finanzdaten für Ishares Genomics Immunology And Healthcare Etf (IDNA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):